These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 19783126)

  • 21. Physical health in schizophrenia: a challenge for antipsychotic therapy.
    Heald A
    Eur Psychiatry; 2010 Jun; 25 Suppl 2():S6-11. PubMed ID: 20620888
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Vigilance level for cardiovascular risk factors in schizophrenic patients].
    Rouillon F; Van Ganse E; Vekhoff P; Arnaud R; Depret-Bixio L; Dillenschneider A
    Encephale; 2015 Feb; 41(1):70-7. PubMed ID: 25637197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study.
    Penno G; Solini A; Bonora E; Fondelli C; Orsi E; Zerbini G; Trevisan R; Vedovato M; Gruden G; Laviola L; Nicolucci A; Pugliese G;
    J Intern Med; 2013 Aug; 274(2):176-91. PubMed ID: 23565931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
    Jerrell JM; McIntyre RS; Tripathi A
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Utilisation of atypical antipsychotic drugs in institutionalised elderly persons and prevalence of metabolic alterations].
    Martínez Romero G; Peris Martí JF; Gomar Fayos J; Navarro Gosalbez M; Quintana Vargas I; Muelas Tirado J
    Farm Hosp; 2010; 34(3):139-47. PubMed ID: 20434929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Metabolic side effects of risperidone in early onset schizophrenia].
    Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
    Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The METEOR study of diabetes and other metabolic disorders in patients with schizophrenia treated with antipsychotic drugs. I. Methodology.
    De Hert M; Mauri M; Shaw K; Wetterling T; Doble A; Giudicelli A; Falissard B
    Int J Methods Psychiatr Res; 2010 Dec; 19(4):195-210. PubMed ID: 20683849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseases.
    Ruiz-García A; Arranz-Martínez E; García-Álvarez JC; Morales-Cobos LE; García-Fernández ME; de la Peña-Antón N; Martín Calle MC; Díez Pérez MC; Montero Costa A; Palacios Martínez D; García Villasur MP; García Granado MAD; Lorenzo Borda MS; Cique Herráinz JA; Marañón Henrich N; Zarzuelo Martín N; Baltuille Aller MDC; Casaseca Calvo TF; Arribas Álvaro P; Macho Del Barrio AI; Moreno Fernández JC; Ribot Catalá C; Capitán Caldas M; Ciria de Pablo C; Sanz Velasco C; Simonaggio Stancampiano P; Vargas-Machuca Cabañero C; Sarriá Sánchez MT; Gómez Díaz E; Sanz Pozo B; Rodríguez de Mingo E; Cabello Igual MP; Rico Pérez MR; Migueláñez Valero A; Alcaraz Bethencourt A; Zafra Urango C; Chao Escuer P; Redondo de Pedro S; Escamilla Guijarro N; López Uriarte B; Rivera Teijido M;
    Clin Investig Arterioscler; 2018; 30(5):197-208. PubMed ID: 29980384
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of co-morbid mental illness on the diagnosis and management of patients hospitalized for medical conditions in a general hospital.
    Briskman I; Bar G; Boaz M; Shargorodsky M
    Int J Psychiatry Med; 2012; 43(4):339-48. PubMed ID: 23094466
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular risk factors in chronic treatment with antipsychotic agents used in primary care.
    Mundet-Tudurí X; Iglesias-Rodal M; Olmos-Domínguez C; Bernard-Antoranz ML; Fernández-San Martín MI; Amado-Guirado E
    Rev Neurol; 2013 Dec; 57(11):495-503. PubMed ID: 24265143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes prevalence estimates in schizophrenia and risk factor assessment.
    Argo T; Carnahan R; Barnett M; Holman TL; Perry PJ
    Ann Clin Psychiatry; 2011 May; 23(2):117-24. PubMed ID: 21547272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychofarmacology in the prevention of somatic comorbid diseases in mentally ill patients.
    Jukić V; Petrović Z; Brecić P; Krizaj A; Savić A; Baceković A; Bilić P; Susac J; Mandić A; Prazen I
    Psychiatr Danub; 2009 Sep; 21(3):350-5. PubMed ID: 19794355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inverse correlation between serum irisin and cardiovascular risk factors among Chinese overweight/obese population.
    Liu R; Zhang Q; Peng N; Xu S; Zhang M; Hu Y; Chen Z; Tang K; He X; Li Y; Shi L
    BMC Cardiovasc Disord; 2021 Nov; 21(1):570. PubMed ID: 34847893
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetes, cardiovascular risk factors and idiopathic sudden sensorineural hearing loss: a case-control study.
    Aimoni C; Bianchini C; Borin M; Ciorba A; Fellin R; Martini A; Scanelli G; Volpato S
    Audiol Neurootol; 2010; 15(2):111-5. PubMed ID: 19657186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal trends in cardiovascular disease risk factor profiles in a population-based schizophrenia sample: a repeat cross-sectional study.
    Chiu M; Rahman F; Vigod S; Wilton AS; Kurdyak P
    J Epidemiol Community Health; 2018 Jan; 72(1):71-77. PubMed ID: 29061843
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comorbidity and cardiovascular risk in subjects with initial diagnosis of hypercholesterolemia].
    Párraga Martínez I; Campo Del Campo JM; Muñoz Sánchez-Villacañas R; Villena Ferrer A; Morena Rayo S; González Felipe N; López-Torres Hidalgo J
    Rev Esp Salud Publica; 2011 Jun; 85(3):305-13. PubMed ID: 21892555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS Study.
    Bobes J; Arango C; Aranda P; Carmena R; Garcia-Garcia M; Rejas J;
    Schizophr Res; 2007 Feb; 90(1-3):162-73. PubMed ID: 17123783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The social transition of risk factors for cardiovascular disease in the African region: evidence from three cross-sectional surveys in the Seychelles.
    Stringhini S; Viswanathan B; Gédéon J; Paccaud F; Bovet P
    Int J Cardiol; 2013 Sep; 168(2):1201-6. PubMed ID: 23206526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic syndrome in outpatients receiving antipsychotic therapy in routine clinical practice: a cross-sectional assessment of a primary health care database.
    Sicras-Mainar A; Blanca-Tamayo M; Rejas-Gutiérrez J; Navarro-Artieda R
    Eur Psychiatry; 2008 Mar; 23(2):100-8. PubMed ID: 17904825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.